Armata Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership

This filing is an initial statement of beneficial ownership for Daniel B. Gilmer, reporting owner and director at Armata Pharmaceuticals, Inc. The filing, dated April 28, 2026, pertains to the period of report ending April 24, 2026. It indicates that Mr. Gilmer does not beneficially own any securities of the company as of the reporting date. The address provided for the reporting owner is in Los Angeles, California.